1.Clinical Manifestations of Laryngopharyngeal Reflux.
Journal of Neurogastroenterology and Motility 2016;22(3):351-352
No abstract available.
Laryngopharyngeal Reflux*
2.The Management of Laryngopharyngeal Reflux Disease.
Korean Journal of Otolaryngology - Head and Neck Surgery 2002;45(9):835-838
No abstract available.
Laryngopharyngeal Reflux*
3.Ultra-Structural and Molecular Aspects of Laryngopharyngeal Reflux.
Korean Journal of Otolaryngology - Head and Neck Surgery 2009;52(5):394-400
No abstract available.
Laryngopharyngeal Reflux
7.Discussing the objective diagnostic methods of laryngopharyngeal reflux.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(19):1536-1540
Laryngopharyngeal reflux (LPR) is gaining extensive attention in recent years because of the high incidence. But because of the complex symptoms and signs, there exist no diagnostic consensus. In this paper, the available objective diagnostic methods so far are reviewed, in the purpose of discussing the approach of objective and accurate diagnosis of LPR.
Humans
;
Laryngopharyngeal Reflux
;
diagnosis
8.The application progress on diagnostic scales of laryngopharyngeal reflux disease.
Yue HAN ; Sen ZHANG ; Hui HUANGFU ; Chenyang LIU ; Chenxu YAN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(4):313-317
At present, objective methods for diagnosing laryngopharyngeal reflux disease(LPRD) are not minimally invasive, effective, and economical. Diagnostic scales are widely used worldwide due to the advantages of inexpensive, noninvasive, and easy to operate. The reflux symptom index(RSI) and the reflux finding score(RFS) are preferred to use in clinical diagnosis. However, many controversies have appeared in the application of RSI and RFS in recent years, causing many troubles to clinical diagnosis. Therefore, this review briefly discusses the problems of RSI and RFS in clinical applications to provide reference for diagnosing LPRD accurately.
Humans
;
Laryngopharyngeal Reflux/diagnosis*
10.Optimal Regimen and Period for the Treatment of Patients with Laryngopharyngeal Reflux Disease.
Yun Jae LEE ; Min Kyu KWAK ; Ji Hun EOM ; Yong Bae JI ; Chang Myeon SONG ; Kyung TAE
Korean Journal of Otolaryngology - Head and Neck Surgery 2014;57(10):698-702
BACKGROUND AND OBJECTIVES: Various drugs can be used for treatment of laryngopharyngeal reflux disease (LPRD). However, the optimal medical treatment regimen is still controversial. This study was performed to determine the optimal medical treatment regimen and duration for LPRD. SUBJECTS AND METHOD: We studied 172 patients who were diagnosed as LPRD by reflux symptom index (RSI) or reflux finding scores (RFS). The study group was divided into 4 groups according to the medication regimen: proton pump inhibitor (PPI), PPI and prokinetics, PPI and H2 blocker, and double dose PPI groups. All patients took medicines for 3 months or more. Clinical remission was defined as 70% improvement of initial RSI scores. RESULTS: 36 (20.9%) patients were prescribed PPI only, 65 (37.8%) patients PPI with prokinetics, 51 (29.6%) patients PPI with H2 blocker, 20 (11.6%) patients double dose PPI. Pretreatment with RSI and RFS did not differ among the four groups. RSI was improved after one month of medication in all of the groups. RSI and RFS tended to decrease during the treatment in all groups (p for trend <0.001). The mean clinical remission time was 2.3 months in patients receiving PPI alone, 2.6 months in PPI and prokinetics group, 2.5 months in the PPI and H2 blocker group and 1.8 months in the double dose PPI group. About 70% of patients reached clinical remission within 3 months. CONCLUSION: PPI with or without prokinetics or H2 blocker is effective treatment for LPRD, and the appropriate duration of medication seems to be about 3 months. Double dose PPI can be used for those whom normal dose PPI is ineffective.
Humans
;
Laryngopharyngeal Reflux*
;
Proton Pumps
Result Analysis
Print
Save
E-mail